Phenotypic study in 40 patients with dysferlin gene mutations: High frequency of atypical phenotypes

Archives of Neurology

Volumn 64, Issue 8, 2007, Pages 1176-1182

  Nguyen, Karine ^a   Bassez, Guillaume ^b,c   Krahn, Martin ^a   Bernard, Rafaelle ^a   Laforêt, Pascal ^b   Labelle, Véronique ^a   Urtizberea, Jon Andoni ^d   Figarella Branger, Dominique ^a   Romero, Norma ^b   Attarian, Shahram ^a   Leturcq, France ^e   Pouget, Jean ^a   Lévy, Nicolas ^a,f   Eymard, Bruno ^b  

^a TIMONE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d European Neuromuscular Center ENMC   (France)

^e Hôpital Cochin ^*  (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSFERLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSFERLINOPATHY; FEMALE; GENE MUTATION; HUMAN; IMAGING SYSTEM; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2B; MALE; MIYOSHI MYOPATHY; MUSCULAR DYSTROPHY; PATHOGENESIS; PHENOTYPE; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 34547882325     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.8.1176     Document Type: Article

References (25)

1. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20(1):37-42.
2. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998;20(1):31-36.
3. Anderson LV, Davison K, Moss JA, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999;8(5):855-861.
4. Laval SH, Bushby KM. Limb-girdle muscular dystrophies: from genetics to molecular pathology. Neuropathol Appl Neurobiol. 2004;30(2):91-105.
5. Mahjneh I, Passos-Bueno MR, Zatz M, et al. The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromuscul Disord. 1996;6(6):483-490.
6. Weiler T, Bashir R, Anderson LV, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet. 1999;8(5):871-877.
7. Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Neurology. 2000;55(12):1931-1933.
8. Aoki M, Liu J, Richard I, et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology. 2001;57(2):271-278.
9. Takahashi T, Aoki M, Tateyama M, et al. Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype. Neurology. 2003;60(11):1799-1804.
10. Tagawa K, Ogawa M, Kawabe K, et al. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients. J Neurol Sci. 2003;211(1-2):23-28.
11. Cagliani R, Fortunato F, Giorda R, et al. Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population. Neuromuscul Disord. 2003;13(10):788-795.
12. Nguyen K, Bassez G, Bernard R, et al. Dysferlin mutations in LGMD2B, Miyoshi myopathy and atypical dysferlinopathies. Hum Mutat. 2005;26(2):165.
13. Gardner-Medwin D, Walton JN. The clinical examination of the voluntary muscles. In: Walton JN, ed. Disorders of Voluntary Muscles. Edinburgh, Scotland: Churchill-Livingstone Inc; 1974:517-560.
14. Anderson LV, Davison K, Moss JA, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 1998;153(4):1169- 1179.
15. Cenacchi G, Fanin M, De Giorgi LB, Angelini C. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol. 2005;58(2):190-195.
16. Suzuki N, Aoki M, Takahashi T, et al. Novel dysferlin mutations and characteristic muscle atrophy in late-onset Miyoshi myopathy. Muscle Nerve. 2004;29(5):721-723.
17. Linssen WH, Notermans NC, Van der Graaf Y, et al. Miyoshi-type distal muscular dystrophy: clinical spectrum in 24 Dutch patients. Brain. 1997;120(Pt 11):1989-1996.
18. Ueyama H, Kumamoto T, Horinouchi H, Fujimoto S, Aono H, Tsuda T. Clinical heterogeneity in dysferlinopathy. Intern Med. 2002;41(7):532-536.
19. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol. 2001;49(1):130-134.
20. Argov Z, Sadeh M, Mazor K, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews: clinical and genetic features. Brain. 2000;123(Pt 6):1229-1237.
21. McNally EM, Ly CT, Rosenmann H, et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet. 2000;91(4):305-312.
22. Anderson LV, Harrison RM, Pogue R, et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (Primary dysferlinopathies). Neuromuscul Disord. 2000;10(8):553-559.
23. Vilchez JJ, Gallano P, Gallardo E, et al. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population. Arch Neurol. 2005;62(8):1256-1259.
24. Kawabe K, Goto K, Nishino I, Angelini C, Hayashi YK. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy. Eur J Neurol. 2004;11(10):657-661.
25. Cagliani R, Magri F, Toscano A, et al. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Hum Mutat. 2005;26(3):283.